Literature DB >> 19925958

Global burden and epidemiology of tuberculosis.

Philippe Glaziou1, Katherine Floyd, Mario Raviglione.   

Abstract

Tuberculosis (TB) ranks second only to human immunodeficiency virus as a cause of death from an infectious agent (1.77 million deaths from TB in 2007). Global targets for reductions in the epidemiologic burden of TB have been set for 2015 and 2050 within the context of the Millennium Development Goals and the Stop TB Partnership. Achieving these targets is the focus of national and international efforts in TB control, and demonstrating whether or not they are achieved is of major importance. This article discusses: the methods used by the World Health Organization to estimate the global burden of TB; estimates of incidence, prevalence, and mortality for 2007, combined with assessment of progress toward the 2015 targets for reductions in these indicators based on trends since 1990 and projections up to 2015; trends in TB notifications and case detection rates; and prospects for elimination of TB by 2050.

Entities:  

Mesh:

Year:  2009        PMID: 19925958     DOI: 10.1016/j.ccm.2009.08.017

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  31 in total

1.  Vaccination of guinea pigs using mce operon mutants of Mycobacterium tuberculosis.

Authors:  Andrés Obregón-Henao; Crystal Shanley; María Verónica Bianco; Angel A Cataldi; Randall J Basaraba; Ian M Orme; Fabiana Bigi
Journal:  Vaccine       Date:  2011-04-22       Impact factor: 3.641

2.  Histopathology and TB-PCR kit analysis in differentiating the diagnosis of intestinal tuberculosis and Crohn's disease.

Authors:  Xian-Ji Jin; Joon-Mee Kim; Hyung-Kil Kim; Lucia Kim; Suk-Jin Choi; In-Suh Park; Jee-Young Han; Young-Chae Chu; Ju-Young Song; Kye-Sook Kwon; Eun-Joo Kim
Journal:  World J Gastroenterol       Date:  2010-05-28       Impact factor: 5.742

3.  Functional analysis of molybdopterin biosynthesis in mycobacteria identifies a fused molybdopterin synthase in Mycobacterium tuberculosis.

Authors:  Monique J Williams; Bavesh D Kana; Valerie Mizrahi
Journal:  J Bacteriol       Date:  2010-10-22       Impact factor: 3.490

Review 4.  Development of new vaccines and drugs for TB: limitations and potential strategic errors.

Authors:  Ian M Orme
Journal:  Future Microbiol       Date:  2011-02       Impact factor: 3.165

Review 5.  Non-prescription antimicrobial use worldwide: a systematic review.

Authors:  Daniel J Morgan; Iruka N Okeke; Ramanan Laxminarayan; Eli N Perencevich; Scott Weisenberg
Journal:  Lancet Infect Dis       Date:  2011-06-12       Impact factor: 25.071

6.  Synthesis and antimycobacterial activity of 2,1'-dihydropyridomycins.

Authors:  Oliver P Horlacher; Ruben C Hartkoorn; Stewart T Cole; Karl-Heinz Altmann
Journal:  ACS Med Chem Lett       Date:  2012-12-18       Impact factor: 4.345

7.  Pathway-selective sensitization of Mycobacterium tuberculosis for target-based whole-cell screening.

Authors:  Garth L Abrahams; Anuradha Kumar; Suzana Savvi; Alvin W Hung; Shijun Wen; Chris Abell; Clifton E Barry; David R Sherman; Helena I M Boshoff; Valerie Mizrahi
Journal:  Chem Biol       Date:  2012-07-27

8.  Pyridomycin bridges the NADH- and substrate-binding pockets of the enoyl reductase InhA.

Authors:  Ruben C Hartkoorn; Florence Pojer; Jon A Read; Helen Gingell; João Neres; Oliver P Horlacher; Karl-Heinz Altmann; Stewart T Cole
Journal:  Nat Chem Biol       Date:  2013-12-01       Impact factor: 15.040

9.  Rolling circle amplification for direct detection of rpoB gene mutations in Mycobacterium tuberculosis isolates from clinical specimens.

Authors:  Xiaoyou Chen; Bin Wang; Wen Yang; Fanrong Kong; Chuanyou Li; Zhaogang Sun; Peter Jelfs; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2014-02-26       Impact factor: 5.948

10.  Methadone treatment improves tuberculosis treatment among hospitalized opioid dependent patients in Ukraine.

Authors:  Olga Morozova; Sergii Dvoryak; Frederick L Altice
Journal:  Int J Drug Policy       Date:  2013-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.